Meristem Family Wealth, LLC Neurocrine Biosciences Inc Transaction History
Meristem Family Wealth, LLC
- $0
- Q3 2022
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
631Shares Held
94.5MCall Options Held
505KPut Options Held
341K-
Black Rock Inc. New York, NY13.8MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.46 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$588 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$338 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$332 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...